Veye Lung Nodules detects, measures, classifies and tracks the growth of pulmonary nodules

Edinburgh, UK & Amsterdam, NETHERLANDS –August 20, 2021 – Blackford, the platform for medical imaging applications and AI, today announced that the Veye Lung Nodules tool is now available on Blackford Platform.

Developed by Aidence, Veye Lung Nodules is an AI-based solution for pulmonary nodule management on chest CT scans. The tool detects, measures, classifies, and tracks the growth of pulmonary nodules as small as 3 mm. The solution is CE-marked as a class IIb medical device under the new EU Medical Device Regulation and can be used as a second or concurrent reader.

Blackford’s single dedicated platform transforms the deployment, orchestration, management and support of multiple imaging applications and AI tools. All applications on the platform are optimized to augment and deliver results within existing workflows, viewers and worklists.

“Blackford offers us a proven platform which provides healthcare professionals immediate access to top-notch AI solutions that add clinical value,” said Mark-Jan Harte, CEO and co-founder of Aidence. “This, together with their partner network and their relentless focus on workflow integration, makes Blackford an ideal partner for Aidence.”

About Aidence
Aidence’s vision is that data is key to improve the prevention, management, and treatment of diseases. Based in the Netherlands and the UK, Aidence rallies over 40 data scientists, medical and regulatory professionals, and software engineers to provide intelligent software for the oncology pathway. For more information, please visit

About Blackford
Blackford delivers a dedicated platform and service for the effective selection, deployment, orchestration and use of best-in-class medical imaging applications and AI. As the most mature and widely deployed dedicated platform provider in the industry, the company is exclusively focused on helping healthcare providers identify and integrate medical imaging applications and AI that benefit their practice. Founded in 2010, and with operations in the United Kingdom and the United States, Blackford Analysis is backed by TRI Cap, Old College Capital, and Archangel Investors.

Media contact: